Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Cash from Operations (2016 - 2025)

OptimizeRx's Cash from Operations history spans 16 years, with the latest figure at 3202000.0 for Q3 2025.

  • For Q3 2025, Cash from Operations rose 78.78% year-over-year to 3202000.0; the TTM value through Sep 2025 reached 11825000.0, up 854.63%, while the annual FY2024 figure was 4889000.0, 167.53% up from the prior year.
  • Cash from Operations for Q3 2025 was 3202000.0 at OptimizeRx, down from 4561000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 4561000.0 in Q2 2025 and bottomed at 6258000.0 in Q4 2023.
  • The 5-year median for Cash from Operations is 1473000.0 (2023), against an average of 1087164.05.
  • The largest annual shift saw Cash from Operations plummeted 868.84% in 2023 before it soared 2562.79% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 1334543.0 in 2021, then surged by 310.07% to 2803484.0 in 2022, then tumbled by 323.22% to 6258000.0 in 2023, then surged by 103.16% to 198000.0 in 2024, then surged by 1517.17% to 3202000.0 in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Cash from Operations are 3202000.0 (Q3 2025), 4561000.0 (Q2 2025), and 3864000.0 (Q1 2025).